137 related articles for article (PubMed ID: 34415623)
1. Radiobiological comparison between Cobalt-60 and Iridium-192 high-dose-rate brachytherapy sources: Part I-cervical cancer.
Dayyani M; Hoseinian-Azghadi E; Miri-Hakimabad H; Rafat-Motavalli L; Abdollahi S; Mohammadi N
Med Phys; 2021 Oct; 48(10):6213-6225. PubMed ID: 34415623
[TBL] [Abstract][Full Text] [Related]
2. Radiobiological and dosimetric comparison of 60Co versus 192Ir high-dose-rate intracavitary-interstitial brachytherapy for cervical cancer.
Wen A; Wang X; Wang B; Yan C; Luo J; Wang P; Li J
Radiat Oncol; 2022 Dec; 17(1):206. PubMed ID: 36514118
[TBL] [Abstract][Full Text] [Related]
3. Estimation and comparison of integral dose to target and organs at risk in three-dimensional computed tomography image-based treatment planning of carcinoma uterine cervix with two high-dose-rate brachytherapy sources:
Yadav S; Singh OP; Choudhary S; Saroj DK; Yogi V; Goswami B
J Cancer Res Ther; 2021; 17(1):191-197. PubMed ID: 33723154
[TBL] [Abstract][Full Text] [Related]
4. Radiobiological optimization comparison between pulse-dose-rate and high-dose-rate brachytherapy in patients with locally advanced cervical cancer.
Annede P; Dumas I; Schernberg A; Tailleur A; Fumagalli I; Bockel S; Mignot F; Kissel M; Deutsch E; Haie-Meder C; Chargari C
Brachytherapy; 2019; 18(3):370-377. PubMed ID: 30797698
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric comparison of
Shukla AK; Jangid PK; Rajpurohit VS; Verma A; Dangayach SK; Gagrani V; Rathore NK
J Cancer Res Ther; 2019; 15(6):1212-1215. PubMed ID: 31898649
[TBL] [Abstract][Full Text] [Related]
6. Boost modalities in cervical cancer: dosimetric comparison between intracavitary BT vs. intracavitary + interstitial BT vs. SBRT.
Benkhaled S; Diakité K; Jullian N; Poeta S; Vandekerkhove C; Van Houtte P; Van Gestel D; De Caluwé A
Radiat Oncol; 2023 Jun; 18(1):105. PubMed ID: 37381016
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive evaluation of adaptive daily planning for cervical cancer HDR brachytherapy.
Meerschaert R; Nalichowski A; Burmeister J; Paul A; Miller S; Hu Z; Zhuang L
J Appl Clin Med Phys; 2016 Nov; 17(6):323-333. PubMed ID: 27929505
[TBL] [Abstract][Full Text] [Related]
8. Direction modulated brachytherapy (DMBT) for treatment of cervical cancer: A planning study with
Safigholi H; Han DY; Mashouf S; Soliman A; Meigooni AS; Owrangi A; Song WY
Med Phys; 2017 Dec; 44(12):6538-6547. PubMed ID: 28940520
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of High Risk Clinical Target Volume reduction during Brachytherapy and impact on its coverage in patients with inoperable cervical cancer.
Pobijakova M; Scepanovic D; Paluga M; Fekete M; Mardiak J
Neoplasma; 2018 Mar; 65(3):425-430. PubMed ID: 29788726
[TBL] [Abstract][Full Text] [Related]
10. Treatment outcomes of high-dose-rate intracavitary brachytherapy for cervical cancer: a comparison of Ir-192 versus Co-60 sources.
Tantivatana T; Rongsriyam K
J Gynecol Oncol; 2018 Sep; 29(5):e86. PubMed ID: 30049023
[TBL] [Abstract][Full Text] [Related]
11. Comparing Iridium-192 with Cobalt-60 sources in high-dose-rate brachytherapy boost for localized prostate cancer.
Tamihardja J; Weick S; Lutyj P; Zimmermann M; Bratengeier K; Flentje M; Polat B
Acta Oncol; 2022 Jun; 61(6):714-719. PubMed ID: 35485446
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric comparison of brachytherapy sources for high-dose-rate treatment of endometrial cancer: (192)Ir, (60)Co and an electronic brachytherapy source.
Mobit PN; Nguyen A; Packianathan S; He R; Yang CC
Br J Radiol; 2016; 89(1059):20150449. PubMed ID: 26743941
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Axxent-Xoft, (192)Ir and (60)Co high-dose-rate brachytherapy sources for image-guided brachytherapy treatment planning for cervical cancer.
Mobit PN; Packianathan S; He R; Yang CC
Br J Radiol; 2015 Aug; 88(1052):20150010. PubMed ID: 25996576
[TBL] [Abstract][Full Text] [Related]
14. A dosimetric comparison of Volumetric Modulated Arc Therapy (VMAT) and High Dose Rate (HDR) brachytherapy in localized cervical cancer radiotherapy.
Wali L; Helal A; Darwesh R; Attar M
J Xray Sci Technol; 2019; 27(3):473-483. PubMed ID: 30958322
[TBL] [Abstract][Full Text] [Related]
15. Practically achievable maximum high-risk clinical target volume doses in MRI-guided intracavitary brachytherapy for cervical cancer: a planning study.
Menon G; Huang F; Sloboda R; Pearcey R; Ghosh S
Brachytherapy; 2014; 13(6):572-8. PubMed ID: 25085455
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric Comparison between Three-Dimensional Magnetic Resonance Imaging-Guided and Conventional Two-Dimensional Point A-Based Intracavitary Brachytherapy Planning for Cervical Cancer.
Ren J; Yuan W; Wang R; Wang Q; Li Y; Xue C; Yan Y; Ma X; Tan L; Liu Z
PLoS One; 2016; 11(9):e0161932. PubMed ID: 27611853
[TBL] [Abstract][Full Text] [Related]
17. Comparison of dosimetric parameters in the treatment planning of magnetic resonance imaging-based intracavitary image-guided adaptive brachytherapy with and without optimization using the central shielding technique.
Nishikawa R; Yoshida K; Ebina Y; Omoteda M; Miyawaki D; Ishihara T; Ejima Y; Akasaka H; Satoh H; Kyotani K; Takahashi S; Sasaki R
J Radiat Res; 2018 May; 59(3):316-326. PubMed ID: 29518234
[TBL] [Abstract][Full Text] [Related]
18. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology.
Pötter R; Haie-Meder C; Van Limbergen E; Barillot I; De Brabandere M; Dimopoulos J; Dumas I; Erickson B; Lang S; Nulens A; Petrow P; Rownd J; Kirisits C;
Radiother Oncol; 2006 Jan; 78(1):67-77. PubMed ID: 16403584
[TBL] [Abstract][Full Text] [Related]
19. Conventional high-dose-rate brachytherapy with concomitant complementary IMRT boost: a novel approach for improving cervical tumor dose coverage.
Duan J; Kim RY; Elassal S; Lin HY; Shen S
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):765-71. PubMed ID: 18164832
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric Considerations for Ytterbium-169, Selenium-75, and Iridium-192 Radioisotopes in High-Dose-Rate Endorectal Brachytherapy.
Shoemaker T; Vuong T; Glickman H; Kaifi S; Famulari G; Enger SA
Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):875-883. PubMed ID: 31330175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
